The problem I have with your argument is that there is an implicit suggestion that the special access request was driven by AVR. Well these is obviously untrue. The decisions were driven by 2 independent KOL cardiologist who are not on the advisory BOARD.AVR is merely providing the products
Ann: Exceptional Results in Second Valve-in-Valve Case, page-14
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.00 |
Change
-0.350(2.02%) |
Mkt cap ! $327.3M | |||
| Open | High | Low | Value | Volume |
| $17.00 | $17.44 | $16.95 | $150.7K | 8.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1552 | $17.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.13 | 8 | 1 |
View Market Depth
| Last trade - 11.26am 19/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |